How the pan-Canadian Oncology Drug Review (pCODR) is changing to accommodate provincial cancer agency needs

CDIAC to CADTH: How the pan-Canadian Oncology Drug Review (pCODR) is changing to accommodate provincial cancer agency needs Date held: March 14th, 2019 Presented by: Gerry Jeffcott, 3Sicty Public Affairs with guest panelists Louise Binder & Martine Elias Webinar Information: This webinar was hosted by Gerry Jeffcott from 3Sixty Public Affairs. He summarized some important changes that the Canadian Agency for Drugs and Technologies in

Canadian Real-world Evidence for Value of Cancer Drugs (CanREValue)

Canadian Real-world Evidence for Value of Cancer Drugs (CanREValue) Date held: March 7th, 2019 Presented by: Dr. Kelvin Chan Webinar Information: Dr. Kelvin Chan gave a short explanation on what real-world evidence (RWE) is, how they can be used in cancer care and what benefits patients can get from the real-world evidence. He will also introduce the Canadian Real-world Evidence for Value of Cancer Drugs

How Timely is Canada’s Medication Review and Approval Process?

How Timely is Canada’s Medication Review and Approval Process? Date held: January 24th, 2019 Presented by: Gerry Jeffcott, 3Sixty Public Affairs with Nigel Rawson & Sarah Lussier Webinar Information: This presentation was hosted by Gerry Jeffcott from 3Sixty Public Affairs, who was joined by two pharmaceutical policy researchers who have conducted analyses of Canada’s access performance over time and in comparison with other countries. The

What’s Happened and Where Are We Headed? Taking Stock on National Pharmacare

What’s Happened and Where Are We Headed? Taking Stock on National Pharmacare Originally Broadcasted: Thursday, December 13th 2018 1:00pm – 2:00pm ET For our last webinar of 2018, we hosted an engaging discussion on the updates in National Pharmacare with panelists Bill Dempster, CEO of 3Sixty Public Affairs and Louse Binder, Health Policy Consultant at Save Your Skin Foundation. View the slide deck: What's Happened

Canadian Partnership Against Cancer: Where has it been, and where is it going?

Canadian Partnership Against Cancer: Where has it been, and where is it going? Originally Broadcasted: Thursday, November 29th 2018 1:00pm – 2:00pm ET The webinar provided an introduction to the Canadian Partnership Against Cancer (CPAC), assessed the results achieved to date by the current Canadian Strategy for Cancer Control and discussed what should be considered in a renewed cancer strategy. In particular, the presentation covered

Oncology Drug Access Navigators: Benefits to Patients & Health Care Teams

Originally broadcast: Thursday, November 15th 2018 1:00pm – 2:00pm ET In this presentation, Alan Birch discussed the role of an Oncology Drug Access Navigator as well as how the role fits into the healthcare team and what they help patients with. He gave a brief overview and history of the role as well as discussing challenges faced by patients and how National Pharmacare may impact